OTCMKTS:AFFY

Affymax (AFFY) Stock Price, News & Analysis

Affymax logo
$0.0008 0.00 (0.00%)
As of 11/16/2026

About Affymax Stock (OTCMKTS:AFFY)

Advanced

Key Stats

Today's Range
$0.0008
▼
$0.0008
50-Day Range
$0.00
▼
$0.04
52-Week Range
$0.00
▼
$0.04
Volume
20 shs
Average Volume
3,939 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Affymax was a biopharmaceutical company focused on developing treatments for anemia and other conditions. Its lead product was peginesatide, marketed as Omontys, which it developed with Takeda Pharmaceutical Company for anemia in adults on dialysis.

After Omontys was approved in the United States in 2012, reports of serious allergic reactions, including fatal cases, led to a product recall in 2013. Affymax then announced it would wind down operations and sought bankruptcy protection. The company is no longer an active drug developer.

AI Generated. May Contain Errors.

Receive AFFY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affymax and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFFY Stock News Headlines

Affymax, Inc. (AFFY)
The Democrats can’t stop this
Porter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypassing Congress under a national emergency. His new briefing outlines three steps to prepare and names a core group of assets tied to the initiative that he says could surge. He points to the 1970s Nixon-era reset, which reportedly minted an average of 1,300 new millionaires a day for over half a century.tc pixel
4 Biotech Stocks Under $5 to Watch
10 Biotech Stocks on Clinical Trials Watch
See More Headlines

AFFY Stock Analysis - Frequently Asked Questions

Affymax's stock was trading at $0.0008 at the beginning of 2026. Since then, AFFY shares have increased by 0.0% and is now trading at $0.0008.

Shares of AFFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:AFFY
CIK
1158223
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
2.86
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:AFFY) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners